[1]
Hamiouda, I., Laouar, R., Salhi, C., Chellat-Rezgoun, D., Khenchoul, Y. , Magra, K.M., Sifi, K. and Satta, D. 2026. A pilot case-control study exploring the association of the XPC Lys939Gln (rs2228001) polymorphism and metabolic risk factors with pancreatic cancer in an Algerian cohort. Archives of Biological Sciences. 78, 2 (Jul. 2026), 143–149. DOI:https://doi.org/10.2298/ABS260412008H.